Additionally, various studies have demonstrated that probiotic and prebiotic supplementation improves glycemic parameters and leptin concentrations in patients affect by obesity, diabetes, and non-alcoholic fatty liver disease (NAFLD) (Table 2). The gene discussed is LEP; the disease is metabolic dysfunction-associated steatotic liver disease.